SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amdocs Limited and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm

THE ANGEL–(BUSINESS WIRE) – Schall law firm, a national law firm specializing in shareholder rights, is reminding investors of a class action lawsuit against Amdocs Limited (“Amdocs” or “the Company”) (NASDAQ: DOX) for violating Sections 10 (b) and 20 (a) des Securities Exchange Act of 1934 and Rule 10b-5 published by the US Securities and Exchange Commission.

Investors who purchased the Company’s securities between December 13, 2016 and March 30, 2021 (including the “Class Period”) are requested to contact the Company before June 8, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights at no charge. You can also contact us on the company’s website at or by email at

In this case, the class has not yet been certified and you will not be represented by a lawyer until certification. If you don’t take action, you can remain an absent class member.

According to the complaint, the company made false and misleading statements to the market. Amdocs has overestimated both its earnings and liquidity while underestimating its debt. The company has kept silent about its sizeable borrowing. The company claimed that its North American business stayed stable but actually deteriorated, in part due to the loss of AT&T as a customer. Because of these facts, the company’s public statements were false and materially misleading throughout the teaching period. When the market learned the truth about Amdocs, investors suffered damage.

Join the case to make up for your losses.

Schall law firm represents investors around the world and specializes in class action and shareholder disputes.

This press release may be viewed as a solicitor’s advertisement in some jurisdictions under applicable laws and ethical rules.

Comments are closed.